autologous bispecific bcma/cd19-targeted car-t cells gc012f vs thalidomide
| autologous bispecific bcma/cd19-targeted car-t cells gc012f | thalidomide | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F | THALIDOMIDE |